Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS
· Delayed Price · Currency is USD
30.57
+0.67 (2.24%)
Mar 9, 2026, 3:59 PM EST
Chugai Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 98,650 | 86,522 | 73,254 | 62,351 | 42,013 | 53,339 | Upgrade
|
| Market Cap Growth | 30.96% | 18.11% | 17.49% | 48.41% | -21.23% | -39.15% | Upgrade
|
| Enterprise Value | 92,456 | 80,893 | 67,877 | 57,961 | 37,878 | 49,894 | Upgrade
|
| Last Close Price | 29.90 | 26.27 | 21.97 | 18.85 | 12.67 | 16.36 | Upgrade
|
| PE Ratio | 35.64 | 31.26 | 29.74 | 27.00 | 14.80 | 20.27 | Upgrade
|
| PS Ratio | 12.30 | 10.78 | 9.84 | 7.91 | 4.40 | 6.14 | Upgrade
|
| PB Ratio | 7.64 | 6.70 | 6.06 | 5.41 | 3.89 | 5.17 | Upgrade
|
| P/TBV Ratio | 7.85 | 6.88 | 6.11 | 5.47 | 3.96 | 5.27 | Upgrade
|
| P/FCF Ratio | 49.89 | 43.76 | 29.00 | 26.01 | 30.53 | 28.74 | Upgrade
|
| P/OCF Ratio | 40.04 | 35.12 | 25.73 | 21.44 | 22.70 | 21.96 | Upgrade
|
| EV/Sales Ratio | 11.62 | 10.08 | 9.12 | 7.35 | 3.97 | 5.75 | Upgrade
|
| EV/EBITDA Ratio | 23.48 | 20.57 | 18.60 | 17.35 | 8.85 | 12.69 | Upgrade
|
| EV/EBIT Ratio | 24.78 | 21.49 | 19.69 | 18.60 | 9.37 | 13.62 | Upgrade
|
| EV/FCF Ratio | 46.76 | 40.91 | 26.87 | 24.17 | 27.52 | 26.89 | Upgrade
|
| Debt / Equity Ratio | - | - | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.02 | 0.03 | 0.02 | 0.04 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.03 | 0.04 | 0.08 | 0.08 | Upgrade
|
| Net Debt / Equity Ratio | -0.48 | -0.48 | -0.52 | -0.45 | -0.34 | -0.38 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.59 | -1.59 | -1.72 | -1.54 | -0.87 | -1.01 | Upgrade
|
| Net Debt / FCF Ratio | -3.16 | -3.16 | -2.48 | -2.15 | -2.69 | -2.13 | Upgrade
|
| Asset Turnover | 0.54 | 0.54 | 0.56 | 0.59 | 0.74 | 0.72 | Upgrade
|
| Inventory Turnover | 1.41 | 1.41 | 1.32 | 1.46 | 1.90 | 1.72 | Upgrade
|
| Quick Ratio | 3.46 | 3.46 | 4.59 | 3.68 | 2.40 | 2.53 | Upgrade
|
| Current Ratio | 4.24 | 4.24 | 5.53 | 4.74 | 3.15 | 3.25 | Upgrade
|
| Return on Equity (ROE) | 22.10% | 22.10% | 21.96% | 21.34% | 28.67% | 27.95% | Upgrade
|
| Return on Assets (ROA) | 15.77% | 15.77% | 16.36% | 14.44% | 19.56% | 19.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 41.72% | 43.67% | 42.57% | 35.09% | 45.09% | 45.33% | Upgrade
|
| Return on Capital Employed (ROCE) | 28.70% | 28.70% | 28.30% | 26.70% | 36.90% | 34.80% | Upgrade
|
| Earnings Yield | 2.81% | 3.20% | 3.36% | 3.70% | 6.76% | 4.93% | Upgrade
|
| FCF Yield | 2.00% | 2.28% | 3.45% | 3.84% | 3.28% | 3.48% | Upgrade
|
| Dividend Yield | 6.03% | 2.96% | 2.84% | 3.01% | 4.67% | 4.04% | Upgrade
|
| Payout Ratio | 68.99% | 68.99% | 34.40% | 40.43% | 36.91% | 32.56% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | Upgrade
|
| Total Shareholder Return | 6.02% | 2.96% | 2.83% | 3.00% | 4.66% | 4.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.